UniProtKB/SwissProt variant VAR

Variant information

Variant position:

425

The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:

LP/P [Disclaimer]

The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Valine (V) to Methionine (M) at position 425 (V425M, p.Val425Met).

Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:

Similar physico-chemical property. Both residues are medium size and hydrophobic.

The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:

1

The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page

Variant description:

In PHGDHD; results in almost undetectable enzyme activity with 3-phosphohydroxypyruvate.

Any additional useful information about the variant.

Other resources:

Links to websites of interest for the variant.

Variant rs121907988 [ dbSNP | Ensembl ]

Sequence information

Variant position:

425

The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:

533

The length of the canonical sequence.

Location on the sequence:

TTSHSPAAPGEQGFGECLLA V ALAGAPYQAVGLVQGTTPVL

The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         TTSHSPAAPGEQGFGECLLAVALAGAPYQAVGLVQGTTPVL

Chimpanzee                    TTSHSPAAPGEQGFGECLLAVALAGAPYQAVGLVQGTTPVL

Mouse                         TTSHNPGVPGEQGSGECLLTVALAGAPYQAVGLVQGTTPML

Rat                           TTSHSPGVPGEQGIGECLLTVALAGAPYQAVGLVQGTTPML

Pig                           TTSHNPAAPEEQGGAECFLTVALAGAPYQAVGLVQGTAPML

Bovine                        TTSHNPATPREQDFGECLLTVALAGAPYQAVGLVQGTKPVL

Slime mold                    LSEFNVSAQVLSTRKQ-------------------------

Baker's yeast                 LSNHNIEKQFSDSNGE-------------------------

Fission yeast                 FIDHNIKSQFSDSRGD-------------------------

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	2 – 533	D-3-phosphoglycerate dehydrogenase

Literature citations

Molecular characterization of 3-phosphoglycerate dehydrogenase deficiency -- a neurometabolic disorder associated with reduced L-serine biosynthesis.
Klomp L.W.J.; de Koning T.J.; Malingre H.E.M.; van Beurden E.A.C.M.; Brink M.; Opdam F.L.; Duran M.; Jaeken J.; Pineda M.; van Maldergem L.; Poll-The B.T.; van den Berg I.E.T.; Berger R.;
Am. J. Hum. Genet. 67:1389-1399(2000)
Cited for: NUCLEOTIDE SEQUENCE [MRNA]; VARIANTS PHGDHD MET-425 AND MET-490;

Novel mutations in 3-phosphoglycerate dehydrogenase (PHGDH) are distributed throughout the protein and result in altered enzyme kinetics.
Tabatabaie L.; de Koning T.J.; Geboers A.J.J.M.; van den Berg I.E.T.; Berger R.; Klomp L.W.J.;
Hum. Mutat. 30:749-756(2009)
Cited for: VARIANTS PHGDHD TRP-135; MET-261; THR-373 AND SER-377; CHARACTERIZATION OF VARIANTS PHGDHD TRP-135; MET-261; THR-373; SER-377; MET-425 AND MET-490; BIOPHYSICOCHEMICAL PROPERTIES;

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot O43175: Variant p.Val425Met